FR2676443B1 - Nouveaux derives de perhydroisoindole et leur preparation. - Google Patents

Nouveaux derives de perhydroisoindole et leur preparation.

Info

Publication number
FR2676443B1
FR2676443B1 FR9106036A FR9106036A FR2676443B1 FR 2676443 B1 FR2676443 B1 FR 2676443B1 FR 9106036 A FR9106036 A FR 9106036A FR 9106036 A FR9106036 A FR 9106036A FR 2676443 B1 FR2676443 B1 FR 2676443B1
Authority
FR
France
Prior art keywords
preparation
halogen atom
symbol
perhydroisoindole derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9106036A
Other languages
English (en)
French (fr)
Other versions
FR2676443A1 (fr
Inventor
Achard Daniel
Grisoni Serge
Hannessian Stephen
Moutonnier Claude
Peyronel Jean-Francois
Tabart Michel
Truchon Alain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9106036A priority Critical patent/FR2676443B1/fr
Priority to CS932448A priority patent/CZ244893A3/cs
Priority to IL101867A priority patent/IL101867A0/xx
Priority to SK1268-93A priority patent/SK126893A3/sk
Priority to DK92911071.6T priority patent/DK0586471T3/da
Priority to US08/146,142 priority patent/US5508433A/en
Priority to DE69201058T priority patent/DE69201058T2/de
Priority to FI935072A priority patent/FI935072A7/fi
Priority to TW081103793A priority patent/TW226991B/zh
Priority to EP92401330A priority patent/EP0514274A1/fr
Priority to MX9202288A priority patent/MX9202288A/es
Priority to ES92911071T priority patent/ES2066620T3/es
Priority to NZ242773A priority patent/NZ242773A/xx
Priority to EP92911071A priority patent/EP0586471B1/fr
Priority to CA002109297A priority patent/CA2109297A1/fr
Priority to ZA923541A priority patent/ZA923541B/xx
Priority to HU9303250A priority patent/HUT68913A/hu
Priority to YU51692A priority patent/YU51692A/sh
Priority to AT92911071T priority patent/ATE116295T1/de
Priority to PCT/FR1992/000430 priority patent/WO1992020654A1/fr
Priority to JP4510463A priority patent/JPH06507628A/ja
Priority to AU18840/92A priority patent/AU1884092A/en
Priority to IE157992A priority patent/IE921579A1/en
Publication of FR2676443A1 publication Critical patent/FR2676443A1/fr
Application granted granted Critical
Publication of FR2676443B1 publication Critical patent/FR2676443B1/fr
Priority to NO933976A priority patent/NO933976L/no
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR9106036A 1991-05-17 1991-05-17 Nouveaux derives de perhydroisoindole et leur preparation. Expired - Lifetime FR2676443B1 (fr)

Priority Applications (24)

Application Number Priority Date Filing Date Title
FR9106036A FR2676443B1 (fr) 1991-05-17 1991-05-17 Nouveaux derives de perhydroisoindole et leur preparation.
CS932448A CZ244893A3 (en) 1991-05-17 1992-05-12 Novel perhydroisoindole derivatives, and process for preparing thereof
IL101867A IL101867A0 (en) 1991-05-17 1992-05-14 Perhydroisoindole derivatives and their preparation
HU9303250A HUT68913A (en) 1991-05-17 1992-05-15 Novel derivatives of perhydroisoindole and preparation thereof
US08/146,142 US5508433A (en) 1991-05-17 1992-05-15 Derivatives of perhydroisoindole and preparation thereof
DE69201058T DE69201058T2 (de) 1991-05-17 1992-05-15 Perhydroisoindol derivate und ihre herstellung.
FI935072A FI935072A7 (fi) 1991-05-17 1992-05-15 Uudet perhydroisoindolit ja niiden valmistus
TW081103793A TW226991B (https=) 1991-05-17 1992-05-15
EP92401330A EP0514274A1 (fr) 1991-05-17 1992-05-15 Nouveaux dérivés de perhydroisoindole et leur préparation
MX9202288A MX9202288A (es) 1991-05-17 1992-05-15 Nuevos derivados de per hidro iso indol y procedimiento para su preparacion.
ES92911071T ES2066620T3 (es) 1991-05-17 1992-05-15 Nuevos derivados de perhidroisoindol y su preparacion.
NZ242773A NZ242773A (en) 1991-05-17 1992-05-15 4,4-diphenylisoindole derivatives
SK1268-93A SK126893A3 (en) 1991-05-17 1992-05-15 Derivatives of perhydroisoindole and preparation thereof
CA002109297A CA2109297A1 (fr) 1991-05-17 1992-05-15 Nouveaux derives de perhydroisoindole et leur preparation
ZA923541A ZA923541B (en) 1991-05-17 1992-05-15 New perhydroisoindole derivatives and their preparation
DK92911071.6T DK0586471T3 (da) 1991-05-17 1992-05-15 Perhydroisoindolderivater og deres fremstilling
YU51692A YU51692A (sh) 1991-05-17 1992-05-15 Novi derivati perhidroizoindola i njihovo dobijanje
AT92911071T ATE116295T1 (de) 1991-05-17 1992-05-15 Perhydroisoindol derivate und ihre herstellung.
PCT/FR1992/000430 WO1992020654A1 (fr) 1991-05-17 1992-05-15 Nouveaux derives de perhydroisoindole et leur preparation
JP4510463A JPH06507628A (ja) 1991-05-17 1992-05-15 新規ペルヒドロイソインドール誘導体及びその製造
AU18840/92A AU1884092A (en) 1991-05-17 1992-05-15 Novel derivatives of perhydroisoindole and preparation thereof
EP92911071A EP0586471B1 (fr) 1991-05-17 1992-05-15 Derives de perhydroisoindole et leur preparation
IE157992A IE921579A1 (en) 1991-05-17 1992-07-01 New perhydroisoindole derivatives and their preparation
NO933976A NO933976L (no) 1991-05-17 1993-11-03 Nye perhydroisoindolderivater og deres fremstilling

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9106036A FR2676443B1 (fr) 1991-05-17 1991-05-17 Nouveaux derives de perhydroisoindole et leur preparation.

Publications (2)

Publication Number Publication Date
FR2676443A1 FR2676443A1 (fr) 1992-11-20
FR2676443B1 true FR2676443B1 (fr) 1993-08-06

Family

ID=9412908

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9106036A Expired - Lifetime FR2676443B1 (fr) 1991-05-17 1991-05-17 Nouveaux derives de perhydroisoindole et leur preparation.

Country Status (23)

Country Link
US (1) US5508433A (https=)
EP (2) EP0586471B1 (https=)
JP (1) JPH06507628A (https=)
AT (1) ATE116295T1 (https=)
AU (1) AU1884092A (https=)
CA (1) CA2109297A1 (https=)
CZ (1) CZ244893A3 (https=)
DE (1) DE69201058T2 (https=)
DK (1) DK0586471T3 (https=)
ES (1) ES2066620T3 (https=)
FI (1) FI935072A7 (https=)
FR (1) FR2676443B1 (https=)
HU (1) HUT68913A (https=)
IE (1) IE921579A1 (https=)
IL (1) IL101867A0 (https=)
MX (1) MX9202288A (https=)
NO (1) NO933976L (https=)
NZ (1) NZ242773A (https=)
SK (1) SK126893A3 (https=)
TW (1) TW226991B (https=)
WO (1) WO1992020654A1 (https=)
YU (1) YU51692A (https=)
ZA (1) ZA923541B (https=)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676442B1 (fr) * 1991-05-17 1993-08-06 Rhone Poulenc Rorer Sa Nouveau derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2689889B1 (fr) * 1992-04-10 1994-06-10 Rhone Poulenc Rorer Sa Nouveaux derives de perhydroisoindole, et leur preparation.
US5508424A (en) * 1993-03-26 1996-04-16 Ortho Pharmaceutical Corporation 4-arylisoindole analgesics
FR2703679B1 (fr) * 1993-04-05 1995-06-23 Rhone Poulenc Rorer Sa Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
TW365603B (en) * 1993-07-30 1999-08-01 Rhone Poulenc Rorer Sa Novel perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them
FR2710913B1 (fr) * 1993-10-07 1995-11-24 Rhone Poulenc Rorer Sa Nouveaux dérivés de perhydroisoindole, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2709752B1 (fr) * 1993-07-30 1995-10-06 Rhone Poulenc Rorer Sa Nouveaux dérivés de perhydroisoindole, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2728166A1 (fr) 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
FR2728165A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
FR2728169A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
FR2741262B1 (fr) 1995-11-20 1999-03-05 Oreal Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
US7163949B1 (en) 1999-11-03 2007-01-16 Amr Technology, Inc. 4-phenyl substituted tetrahydroisoquinolines and use thereof
MXPA02004330A (es) 1999-11-03 2004-07-30 Albany Molecular Res Inc Tetrahidroisoquinolinas aril-y heteroaril-sustituidas y uso de las mismas para bloquear la recaptacion de norepinefrina, dopamina y serotonina..
KR100821410B1 (ko) 2000-07-11 2008-04-10 에이엠알 테크놀로지, 인크. 4-페닐 치환된 테트라하이드로이소퀴놀린 및 이의치료학적 용도
US6709651B2 (en) 2001-07-03 2004-03-23 B.M.R.A. Corporation B.V. Treatment of substance P-related disorders
UA91341C2 (ru) 2004-07-15 2010-07-26 Амр Текнолоджи, Інк. Арил- и гетероарилзамещенные тетрагидроизохинолины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина
WO2006123182A2 (en) 2005-05-17 2006-11-23 Merck Sharp & Dohme Limited Cyclohexyl sulphones for treatment of cancer
UA95454C2 (uk) 2005-07-15 2011-08-10 Амр Текнолоджи, Інк. Арил- і гетероарилзаміщені тетрагідробензазепіни і їх застосування для блокування зворотного захоплення норепінефрину, допаміну і серотоніну
GB0603041D0 (en) 2006-02-15 2006-03-29 Angeletti P Ist Richerche Bio Therapeutic compounds
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
AR064777A1 (es) 2007-01-10 2009-04-22 Inst Di Reserche D Biolog Mole Indazoles sustituidos con amida como inhibidores de poli (adp- ribosa) polimerasa (parp)
EP3103791B1 (en) 2007-06-27 2018-01-31 Merck Sharp & Dohme Corp. 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
AR071997A1 (es) 2008-06-04 2010-07-28 Bristol Myers Squibb Co Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
WO2010114780A1 (en) 2009-04-01 2010-10-07 Merck Sharp & Dohme Corp. Inhibitors of akt activity
AU2010247763B2 (en) 2009-05-12 2015-12-24 Albany Molecular Research, Inc. 7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof
US8815894B2 (en) 2009-05-12 2014-08-26 Bristol-Myers Squibb Company Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
EP2429295B1 (en) 2009-05-12 2013-12-25 Albany Molecular Research, Inc. Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
US8859776B2 (en) 2009-10-14 2014-10-14 Merck Sharp & Dohme Corp. Substituted piperidines that increase p53 activity and the uses thereof
CA2805265A1 (en) 2010-08-02 2012-02-09 Merck Sharp & Dohme Corp. Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)
WO2012024170A2 (en) 2010-08-17 2012-02-23 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
US8883801B2 (en) 2010-08-23 2014-11-11 Merck Sharp & Dohme Corp. Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
WO2012030685A2 (en) 2010-09-01 2012-03-08 Schering Corporation Indazole derivatives useful as erk inhibitors
US9242981B2 (en) 2010-09-16 2016-01-26 Merck Sharp & Dohme Corp. Fused pyrazole derivatives as novel ERK inhibitors
WO2012058210A1 (en) 2010-10-29 2012-05-03 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA)
EP2654748B1 (en) 2010-12-21 2016-07-27 Merck Sharp & Dohme Corp. Indazole derivatives useful as erk inhibitors
WO2012143879A1 (en) 2011-04-21 2012-10-26 Piramal Healthcare Limited A crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation
EP2770987B1 (en) 2011-10-27 2018-04-04 Merck Sharp & Dohme Corp. Novel compounds that are erk inhibitors
WO2013165816A2 (en) 2012-05-02 2013-11-07 Merck Sharp & Dohme Corp. SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
WO2014052563A2 (en) 2012-09-28 2014-04-03 Merck Sharp & Dohme Corp. Novel compounds that are erk inhibitors
ME02925B (me) 2012-11-28 2018-04-20 Merck Sharp & Dohme Kompozicije i postupci za liječenje kancera
TW201429969A (zh) 2012-12-20 2014-08-01 Merck Sharp & Dohme 作爲ｈｄｍ２抑制劑之經取代咪唑吡啶
WO2014120748A1 (en) 2013-01-30 2014-08-07 Merck Sharp & Dohme Corp. 2,6,7,8 substituted purines as hdm2 inhibitors
US20160194368A1 (en) 2013-09-03 2016-07-07 Moderna Therapeutics, Inc. Circular polynucleotides
US10975084B2 (en) 2016-10-12 2021-04-13 Merck Sharp & Dohme Corp. KDM5 inhibitors
US10947234B2 (en) 2017-11-08 2021-03-16 Merck Sharp & Dohme Corp. PRMT5 inhibitors
EP3706747B1 (en) 2017-11-08 2025-09-03 Merck Sharp & Dohme LLC Prmt5 inhibitors
WO2020033282A1 (en) 2018-08-07 2020-02-13 Merck Sharp & Dohme Corp. Prmt5 inhibitors
WO2020033288A1 (en) 2018-08-07 2020-02-13 Merck Sharp & Dohme Corp. Prmt5 inhibitors
US11981701B2 (en) 2018-08-07 2024-05-14 Merck Sharp & Dohme Llc PRMT5 inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4042707A (en) * 1976-02-19 1977-08-16 E. I. Du Pont De Nemours And Company 3α-Arylhydroisoindoles
AU502760B2 (en) * 1977-02-28 1979-08-09 Science Union Et Cie, Societe Francaise De Recherche Medicale Azabicycloalkanes and their preparation
EP0093805B1 (en) * 1981-02-17 1987-05-13 Warner-Lambert Company Octahydro-2-(omega-mercaptoalkanoyl)3-oxo-1h-isoindole-1-carboxylic acids and esters
US4439229A (en) * 1981-06-29 1984-03-27 Rohm And Haas Company Substituted phthalimides herbicides
JPH0278659A (ja) * 1988-09-12 1990-03-19 Shionogi & Co Ltd アザビシクロアルカン類化合物
FR2654725B1 (fr) * 1989-11-23 1992-02-14 Rhone Poulenc Sante Nouveaux derives de l'isoindolone, leur preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
AU1884092A (en) 1992-12-30
IL101867A0 (en) 1992-12-30
ATE116295T1 (de) 1995-01-15
IE921579A1 (en) 1992-11-18
YU51692A (sh) 1994-06-10
CZ244893A3 (en) 1994-04-13
DE69201058D1 (de) 1995-02-09
EP0514274A1 (fr) 1992-11-19
MX9202288A (es) 1992-11-01
NO933976D0 (no) 1993-11-03
ES2066620T3 (es) 1995-03-01
ZA923541B (en) 1993-01-27
HUT68913A (en) 1995-08-28
DK0586471T3 (da) 1995-06-06
NZ242773A (en) 1994-06-27
US5508433A (en) 1996-04-16
JPH06507628A (ja) 1994-09-01
TW226991B (https=) 1994-07-21
FI935072A0 (fi) 1993-11-16
CA2109297A1 (fr) 1992-11-18
EP0586471A1 (fr) 1994-03-16
FR2676443A1 (fr) 1992-11-20
HU9303250D0 (en) 1994-03-28
WO1992020654A1 (fr) 1992-11-26
FI935072L (fi) 1993-11-16
NO933976L (no) 1993-11-03
SK126893A3 (en) 1994-11-09
DE69201058T2 (de) 1995-05-11
FI935072A7 (fi) 1993-11-16
EP0586471B1 (fr) 1994-12-28

Similar Documents

Publication Publication Date Title
FR2676443B1 (fr) Nouveaux derives de perhydroisoindole et leur preparation.
FR2749304B1 (fr) Nouveaux derives du 3-(piperid-4-yl)1,2-benzisoxazole et du 3-(piperazin-4-yl)1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2654726B1 (fr) Nouveaux derives de l'isoindolone et leur preparation.
ATE214393T1 (de) Bis(3,4-dialkylbenzyliden)sorbitolacetale und diese enthaltende zusammensetzungen
FI924381A0 (fi) Derivat av pyrimidinnukleosid med tumoermotverkande effekt, framstaellning och anvaendning av dessa.
DK0782997T3 (da) Triazolopyrimidinderivater
UA26401C2 (uk) Заміщеhі 3-аміhохіhуклідиhи
SE8107537L (sv) Nya derivat av heterocykliska aminoalcoyler, deras framstellningssett och deras terapeutiska anvendning
FI965020A0 (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
MX9806246A (es) PIPERIDINAS NOVEDOSAS DERIVADAS DE 1-/(PIPERAZIN-1-IL)ARIL-(OXI/AMINO)CARBONIL(4-ARIL-PIPERIDIN A COMO ANTAGONISTAS SELECTIVOS DEL RECEPTOR 5-HT-1D- beta-.
ES2169220T3 (es) Derivados de vitamina d3 con sustituyentes en la posicion 2.
DK0700914T3 (da) Campththecinderivater, deres fremstilling og antitumormidler
SE9001269D0 (sv) 2-substituted n,n-ditrimethoxybenzoyl piperazines,a preparation process of the same and therapeutic compositions containing them
ATE111887T1 (de) Mesomorphe verbindung, sie enthaltende flüssigkristalline zusammensetzung, sie verwendende flüssigkristalline vorrichtung und anzeigeapparat.
FR2616433B1 (fr) Nouveaux derives piperazinyl alkyl piperazine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2625647B1 (fr) Association herbicide synergique a base de bifenox et de sulfonamides
NO842345L (no) Heksahydropyrrolo(2,1-a)isoquinolin-derivater.
FR2601364B1 (fr) Nouveaux derives de la piperazine dione-2,6, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
RU93058289A (ru) Производные пергидроизоиндола, способы их получения
FR2611715B1 (fr) Nouveaux acetamides derives de la dihydro-2,3 phenyl-3 benzofurannone-2, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
ATE91487T1 (de) Dibenzodioxazecin- und dibenzodioxaazacycloundecin-derivate.